Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 735761, 4 pages
http://dx.doi.org/10.1155/2013/735761
Research Article

Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran

1Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Gastroenterology, Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Received 2 March 2013; Accepted 31 March 2013

Academic Editors: A. Aghakhani, M. Banifazl, and A. Ramezani

Copyright © 2013 Daneshmand Dana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Almasio, S. Babudieri, G. Barbarini et al., “Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates),” Digestive and Liver Disease, vol. 43, no. 8, pp. 589–595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. F. Liaw and C. M. Chu, “Hepatitis B virus infection,” The Lancet, vol. 373, no. 9663, pp. 582–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. M. Scott, R. Snitbhan, and W. H. Bancroft, “Experimental transmission of hepatitis B virus by semen and saliva,” Journal of Infectious Diseases, vol. 142, no. 1, pp. 67–71, 1980. View at Google Scholar · View at Scopus
  4. L. Han, H. W. Zhang, J. X. Xie, Q. Zhang, H. Y. Wang, and G. W. Cao, “A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus,” World Journal of Gastroenterology, vol. 17, no. 38, pp. 4321–4333, 2011. View at Google Scholar
  5. A. L. Estrada, “Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users,” Public Health Reports, vol. 117, no. 1, supplement, pp. S126–S134, 2002. View at Google Scholar · View at Scopus
  6. R. S. Garfein, D. Vlahov, N. Galai, M. C. Doherty, and K. E. Nelson, “Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses,” American Journal of Public Health, vol. 86, no. 5, pp. 655–661, 1996. View at Google Scholar · View at Scopus
  7. M. Sofian, A. Aghakhani, M. Banifazl, K. Azadmanesh, A. A. Farazi, and W. McFarland, “Viral hepatitis and HIV infection among injection drug users in a central Iranian City,” Journal of Addiction Medicine, vol. 6, no. 4, pp. 292–296, 2012. View at Google Scholar
  8. J. Poorolajal and R. Majdzadeh, “Prevalence of chronic hepatitis B infection in Iran: a review article,” Journal of Research in Medical Sciences, vol. 14, no. 4, pp. 249–258, 2009. View at Google Scholar · View at Scopus
  9. H. Tavakkoli, M. M. Mir-Nasseri, H. Poustchi et al., “Prevalence and risk factors of hepatitis B infection in injection drug users, Tehran (2001-2002),” Hepatitis Monthly, vol. 8, no. 1, pp. 29–33, 2008. View at Google Scholar · View at Scopus
  10. N. Kassaian, P. Adibi, A. Kafashaian, M. Yaran, Z. Nokhodian, and P. Shoaei, “Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan,” International Journal of Preventive Medicine, no. 3, supplement 1, pp. S156–S161, 2012. View at Google Scholar
  11. E. J. Nelwan, R. Van Crevel, B. Alisjahbana, A. K. Indrati, R. F. Dwiyana, and N. Nuralam, “Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening,” Tropical Medicine & International Health, vol. 15, no. 12, pp. 1491–1498, 2010. View at Google Scholar
  12. A. C. F. Stief, R. M. B. Martins, S. M. O. de Andrade et al., “Seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, Brazil,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 43, no. 5, pp. 512–515, 2010. View at Google Scholar · View at Scopus
  13. J. Long, S. Allwright, J. Barry et al., “Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey,” British Medical Journal, vol. 323, no. 7323, pp. 1209–1212, 2001. View at Google Scholar · View at Scopus
  14. S. Babudieri, B. Longo, L. Sarmati et al., “Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy,” Journal of Medical Virology, vol. 76, no. 3, pp. 311–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Nokhodian, M. R. Yazdani, M. Yaran, P. Shoaei, M. Mirian, and B. Ataei, “Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan, Iran,” Hepatitis Monthly, vol. 12, no. 7, pp. 442–447, 2012. View at Google Scholar
  16. N. Kassaian, B. Ataei, M. Yaran, A. Babak, and P. Shoaei, “Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: seroprevalence and associated factors,” Hepatitis Monthly, vol. 11, no. 5, pp. 368–371, 2011. View at Google Scholar · View at Scopus
  17. M. M. Mir-Nasseri, A. Mohammadkhani, H. Tavakkoli, E. Ansari, and H. Poustchi, “Incarceration is a major risk factor for blood-borne infection among intravenous drug users,” Hepatitis Monthly, vol. 11, no. 1, pp. 19–22, 2011. View at Google Scholar · View at Scopus
  18. S. Zamani, S. Ichikawa, B. Nassirimanesh et al., “Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran,” International Journal of Drug Policy, vol. 18, no. 5, pp. 359–363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Stark, U. Bienzle, R. Vonk, and I. Guggenmoos-Holzmann, “History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin,” International Journal of Epidemiology, vol. 26, no. 6, pp. 1359–1366, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. M. P. Adoga, E. B. Banwat, J. C. Forbi et al., “Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria,” Journal of Infection in Developing Countries, vol. 3, no. 7, pp. 539–547, 2009. View at Google Scholar · View at Scopus